Top View
- Isolation and Preliminary Characterization of an Adriamycin-Resistant Murine Fibrosarcoma Cell Line1
- Inhibitors of the Menin-Mll Interaction Inhibitoren Der Menin-Mll-Interaktion Inhibiteurs De L’Interaction Ménine-Mll
- Teniposide Injection
- The Hi's and Lo's of Cytarabine in Acute Myeloid Leukemia
- 1. NAME of the MEDICINAL PRODUCT Amsidine, Concentrate for Solution for Intravenous Infusion 75 Mg/ 1,5 Ml 2. QUALITATIVE and QU
- Synthesis, Antitumor Activity, and DMA Binding Properties of A
- The Hi S and Lo S of Cytarabine in Acute Myeloid Leukemia
- NCCN Guidelines for Acute Myeloid Leukemia from the 1.2014 Version Include
- Randomized Trial of Intermediate-Dose Cytarabine In
- Schedule-Dependent Synergism and Antagonism Between Methotrexate
- Liste Des Molécules
- The DNA Topoisomerase II Inhibitor Amsacrine As a Novel Candidate
- Camptothecin, Teniposide, Or 4
- (12) United States Patent (10) Patent No.: US 6,664,288 B1 Pardee Et Al
- Arsenic Trioxide (As 2 O 3) Gradually Downregulates Tissue Factor
- Orphan Drugs in Asia Report 2014
- Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA
- Neutropenic Enterocolitis in a Woman Treated with 5-Fluorouracil and Leucovorin for Colon Carcinoma
- Chemotherapy Drugs
- Mitoxantrone
- Guideline for Classification of the Acute Emetogenic Potential of Antineoplastic Medication in Pediatric Cancer Patients
- Chemical Compatibility of Chemoclave™ and Chemolock™
- DRUG NAME Toxicities: Acute: Delayed: Subclass Mechanism of Action
- Pharmacokinetic and Toxicity Scaling of the Antitumor Agents Amsacrine and CI-921, a New Analogue, in Mice, Rats, Rabbits, Dogs, and Humans'
- Conditioning Regimens Continuous Infusion Idarubicin and Oral
- Gemcitabine and Cisplatin) in Combination with Conventional Transarterial Chemoembolization (Ctace) in Patients with Advanced Intra-Hepatic Cholangiocarcinoma (ICC)
- Adverse Mucocutaneous Reactions Related to Chemothera- Peutic Agents – Part II Reações Tegumentares Adversas Relacionadas Aos Agentes Antineoplásicos – Parte II
- An Open Access Database of Licensed Cancer Drugs Pan Pantziarka 1,2, §, Rica Capistrano 1, Arno De Potter 3, Liese Vandeborne 1, Gauthier Bouche 1
- Do Not Tube List
- WO 2017/035116 Al O
- List Item Withdrawal Assessment Report for Tekinex (PDF/558.5
- Arsenic (Trioxide)
- DNA-Binding Anticancer Drugs: One Target, Two Actions
- Association of Immunophenotype with Expression of Topoisomerase II Α and Β in Adult Acute Myeloid Leukemia Andrew P
- Medications That Are Considered Hazardous
- PRESCRIBING INFORMATION AMSA PD* Amsacrine Injection 75 Mg/1.5 Ml Ampoule
- Gemcitabine Induces Parkin-Independent Mitophagy
- Antineoplastic Drugs